Multifunction Cardiogram

CALL TO SCHEDULE YOUR MCG

Some alarming statistics…

Heart disease is the leading cause of death for men and women. –
CDC

More than 659,000 people die of heart disease in the United States
every year. – CDC Heart Care

Heart disease is the leading cause of death for men and women. –
CDC

More than 659,000 people die of heart disease in the United States
every year. – CDC

1 in every 4 deaths is cardiac related or 1 person every 36 seconds. –
American Heart Association

Over 300,000 people in the U.S. die of sudden cardiac death every
year. – American Heart Association

Most heart attacks happen with less than 50% blockage.– American
Heart Association

No current test detects microvascular disease in small vessels which is
the most undiagnosed condition of women’s heart disease as well as
the leading cause of death in women.

Approximately two in ten deaths from coronary heart disease happen
in adults less than 65 years of age. – CDC

30% of heart attacks have no warning. – Mayo Clinic
Underlying factors begin the process 10+ years before a heart attack
occurs.

1 in every 4 deaths is cardiac related or 1 person every 36 seconds. –
American Heart Association

1 in every 3 deaths in women is cardiac related. More than breast
cancer and other cancers combined. -American Heart Association

Over 300,000 people in the U.S. die of sudden cardiac death every
year. – American Heart Association

Most heart attacks happen with less than 50% blockage.– American
Heart Association

Approximately two in ten deaths from coronary heart disease happen
in adults less than 65 years of age. – CDC

30% of heart attacks have no warning. – Mayo Clinic

Underlying factors begin the process 10+ years before a heart attack
occurs.

 When identified early, heart disease can be completely reversed.

Links to above facts:
https://www.cdc.gov/
https://www.heart.org/
https://www.mayoclinic.org/
https://www.cdc.gov/heartdisease/women.htm

COPY:

Recently our office has adopted a groundbreaking new technology called the
Multifunction Cardiogram™.  The MCG™ is an advancement in cardiac diagnostics that
allows us to see issues in your heart that we’ve never been able to see before. We are
so excited to bring this test to our patients! 

Coronary Artery Disease (CAD) in all stages, including early onset
Microvascular Disease, a common problem for women left undetected by other
methods

 Rhythm Disturbances, even before they are noticed by most patients
 Heart Stiffening before heart failure is a clinical entity
 Myocarditis
 Plaque Instabilities
 Even low-level blockages with high accuracy

Most people don’t know they have heart disease until it’s too late. Last year
in the United States, 325,000 people died of sudden cardiac death, and for
most, the heart attack was their first symptom. In about ten minutes, the
MCG™ identifies obstructive coronary artery disease with the highest
accuracy available in cardiac diagnostic testing, as well as any causes which
would lead to supply and demand imbalances of the entire cardiovascular
system, physiologically.

When compared to other diagnostic modalities, MCG™ is extremely accurate
and reliable, surpassing most established clinical techniques in both
sensitivity and specificity. No current test than MCG™detects microvascular
disease in small vessels which is the most undiagnosed condition of women’s
heart disease as well as the leading cause of death in women. In addition,
MCG™ is capable of accurately detecting coronary artery disease at earlier
stages, allowing intervention at stages where CAD may be controlled by
lifestyle changes, medications, or, better yet, can be reversed.

MCG™’s greatest value is undoubtedly in the primary care arena.  Until
now, heart disease was principally only detectable in advanced
stages.  MCG™ technology delivers unprecedented early disease pattern
detection capabilities. Now patients with early-stage indicators can forge a
plan with their physicians to reverse their symptoms, increasing their
lifespans potentially by decades. MCG™ testing is safe for all patients,
regardless of age, and is recommended annually for patients beginning at
age 30.  Even as early as age 14, MCG™ testing makes sense for athletes or
those genetically predisposed to heart disease.

The MCG™ scan helps the patient and physician accurately understand the
patient’s risk of heart disease.  The test results provide vital information
allowing medical providers to formulate a plan of functional recovery so
that their patients do not become one of the startling statistics.

Many factors play a role in heart disease, including environmental toxins,
hormonal imbalances, metabolic imbalances, the physical construction of the
heart, and overall health and wellbeing. Once a baseline has been
established with MCG™ testing, providers can continue to monitor the
success of the treatment plan using periodic MCG™ testing to accurately
determine the advancement or reversal of symptoms.

Heart disease is preventable, which makes the importance of early detection
and treatment essential. It is most often reversible, even in late stages. The
adoption of heart healthy nutrition and healthy lifestyle habits have been
shown to improve cardiovascular health and potentially reverse coronary
atherosclerosis and/or slow or stop the progression of the disease. However,
patients often need to be re-educated about exercise and diet
considerations.

The fact that the initial presentation for half of men and women with
coronary artery disease (CAD) is sudden death or a heart attack is a
stunning indictment of our historic inability to accurately diagnose and treat
coronary artery disease. Current diagnostic methods often miss disease or
lead to potentially harmful interventions for presumed clinically significant
disease that is not present. In short, the “state-of-the-art” tools used to
diagnose CVD, particularly CAD, and measure progression or regression of
disease are, sadly, far less than adequate.

The MCG™ device brings cardiovascular disease diagnosis into the 21st
century. Patients, ages 14 and up, can benefit from having an MCG™ scan
performed to determine their level of risk. MCG™ technology provides the
quick, clear, and objective data needed for medical providers to assess the
condition of a patient’s heart and cardiovascular system. MCG™ offers risk-
free testing that is:
 Non-invasive
 Quick-less than 10 minutes
 Cost-effective-per test cost is comparable to other resting ECG
procedures
 FDA approved
 Stress Free
 Chemical Free
 Radiation Free